BIOMAT Database Logo BIOMAT Database Logo

Disruption of OTC promoter-enhancer interaction in a patient with symptoms of ornithine carbamoyltransferase deficiency. 2010

Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Laboratory of Experimental Hepatology, Institute for Clinical and Experimental Medicine, Prague.

In a female patient with signs of ornithine carbamoyltransferase deficiency (OTCD), the only variation found was a heterozygous single nucleotide substitution c.-366A>G. Determination of transcription start sites of human OTC 95, 119 and 169 bp upstream of the initiation codon located the variation upstream of the 5'-untranslated region. We predicted the human promoter and enhancer elements from homology with rat and mouse, performed function analysis of both regulatory regions and assessed the impact of the promoter variation in functional studies using dual luciferase reporter assay. Our data indicate that: (i) Full transcriptional activity of human OTC promoter depends on an upstream enhancer, as do the rodent promoters. (ii) The promoter variation c.-366A>G does not affect the function of the promoter alone but it disrupts the interaction of the promoter with the enhancer. (iii) The promoter-enhancer interaction contributes to tissue specific expression of OTC in the liver. We conclude that mutations in the regulatory regions of OTC can lead to OTCD and should be included in genetic testing.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009954 Ornithine Carbamoyltransferase A urea cycle enzyme that catalyzes the formation of orthophosphate and L-citrulline (CITRULLINE) from CARBAMOYL PHOSPHATE and L-ornithine (ORNITHINE). Deficiency of this enzyme may be transmitted as an X-linked trait. EC 2.1.3.3. Ornithine Transcarbamylase,Ornithine Carbamylphosphate Transferase,Carbamoyltransferase, Ornithine,Carbamylphosphate Transferase, Ornithine,Transcarbamylase, Ornithine,Transferase, Ornithine Carbamylphosphate
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell

Related Publications

Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Gene symbol: OTC. Disease: ornithine carbamoyltransferase deficiency.
September 2003, Human genetics,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Gene symbol: OTC. Disease: ornithine carbamoyltransferase deficiency.
September 2003, Human genetics,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency.
May 2012, Journal of Korean medical science,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Ornithine carbamoyltransferase deficiency.
January 2001, Archives of disease in childhood,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
July 2017, Clinical chemistry and laboratory medicine,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
[Ornithine carbamoyltransferase deficiency. A clinical case].
April 2015, Archivos argentinos de pediatria,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Ornithine carbamoyltransferase deficiency presenting with chorea in a female.
December 2000, Journal of inherited metabolic disease,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Ornithine carbamoyltransferase deficiency with subnormal enzyme activity.
January 1991, Journal of inherited metabolic disease,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
Hyperammonemia caused by impaired mitochondrial ornithine transport in a patient with partial quantitative deficiency of ornithine carbamoyltransferase.
April 1990, Clinical biochemistry,
Ondrej Luksan, and Milan Jirsa, and Jitka Eberova, and Jakub Minks, and Helena Treslova, and Michaela Bouckova, and Gabriela Storkanova, and Hana Vlaskova, and Martin Hrebicek, and Lenka Dvorakova
[Genetic counseling in ornithine carbamoyltransferase deficiency].
January 1988, Annales de biologie clinique,
Copied contents to your clipboard!